MedTrace Logo

Single-cycle Remote Ischemic Preconditioning and Postconditioning (SCRIP) Trial

NCT02649309 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 370

Last updated 2018-08-31

No results posted yet for this study

Summary

This trial is a 2 x 2 factorial design, double-blinded, randomized controlled trial to evaluate efficacy and safety of remote ischemic preconditioning and postconditioning in patient undergoing coronary angioplasty.

Conditions

  • Ischemic Reperfusion Injury

Interventions

PROCEDURE

RIPre

Preconditioning 200 mmHg x 5 minutes before procedure

PROCEDURE

Sham-Pre

Sham 10 mmHg x 5 minutes before procedure

PROCEDURE

RIPost

Postconditioning 200 mmHg x 5 minutes after procedure

PROCEDURE

Sham-Post

Sham 10 mmHg x 5 minutes after procedure

Sponsors & Collaborators

  • Phramongkutklao College of Medicine and Hospital

    lead OTHER

Principal Investigators

  • Nakarin Sansanayudh, MD,PhD · Department of Internal Medicine, Phramongkutklao Hospital, Bangkok, Thailand

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2019-05-31
Completion
2019-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02649309 on ClinicalTrials.gov